Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A propensity score-matched analysis of oncological outcome after systemic therapy for stage IV colorectal cancer: Impact of synchronous ovarian metastases.

Autor: van der Meer R; Department of Surgery, Máxima Medical Centre, Veldhoven, The Netherlands., Bakkers C; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., van Erning FN; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Simkens LHJ; Department of Medical Oncology, Máxima Medical Centre, Veldhoven, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.; GROW-School for Oncology and Development Biology, Maastricht University, Maastricht, The Netherlands., Roumen RMH; Department of Surgery, Máxima Medical Centre, Veldhoven, The Netherlands.; GROW-School for Oncology and Development Biology, Maastricht University, Maastricht, The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2023 Mar 15; Vol. 152 (6), pp. 1174-1182. Date of Electronic Publication: 2022 Oct 28.

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.

Autor: Wensink GE; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Elferink MAG; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508GA, Utrecht, The Netherlands., Mol L; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., Hamers PAH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Bakker SD; Department of Medical Oncology, Zaans Medical Center, Postbus 210, 1500EE, Zaandam, The Netherlands., Creemers GJ; Department of Medical Oncology, Catharina Hospital, Postbus 1350, 5602ZA, Eindhoven, The Netherlands., de Groot JWB; Department of Medical Oncology, Isala Hospital, Dokter van Heesweg 2, 8025AB, Zwolle, The Netherlands., de Klerk GJ; Department of Medical Oncology, Spaarne Gasthuis, Spaarnepoort 1, 2134TM, Hoofddorp, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Postbus 9100, 3007AC, Rotterdam, The Netherlands., Haringhuizen AW; Department of Medical Oncology, Hospital Gelderse Vallei, Willy Brandtlaan 10, 6716RP, Ede, The Netherlands., Hoekstra R; Department of Medical Oncology, Ziekenhuisgroep Twente, Postbus 7600, 7600SZ, Almelo, The Netherlands., Hunting JCB; Department of Medical Oncology, St. Antonius Hospital, Postbus 2500, 3430EM, Nieuwegein, The Netherlands., Kerver ED; Department of Medical Oncology, OLVG, Oosterpark 9, 1091AC, Amsterdam, The Netherlands., Mathijssen-van Stein D; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Vlietlandplein, 3118JH, Schiedam, The Netherlands., Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Postbus 888, 8901BR, Leeuwarden, The Netherlands., Pruijt JFM; Department of Medical Oncology, Jeroen Bosch Hospital, Postbus 90153, 5200ME, 's-Hertogenbosch, The Netherlands., Quarles van Ufford-Mannesse P; Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545AA, den Haag, The Netherlands., Radema S; Department of Medical Oncology, Radboud University Medical Center, Postbus 9101, 6500HB, Nijmegen, the Netherlands., Rietbroek RC; Department of Medical Oncology, Rode Kruis Hospital, Postbus 1074, 1940EB, Beverwijk, The Netherlands., Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Postbus 90052, 5600PD, Eindhoven, The Netherlands., Tanis BC; Department of Medical Oncology, Groene Hart Hospital, Bleulandweg 10, 2803HH, Gouda, The Netherlands., Ten Bokkel Huinink D; Department of Medical Oncology, Diakonessenhuis Utrecht, Postbus 80250, 3508TG, Utrecht, The Netherlands., Tjin-A-Ton MLR; Department of Medical Oncology, Hospital Rivierenland, President Kennedylaan 1, 4002WP, Tiel, The Netherlands., Tromp-van Driel CS; Department of Medical Oncology, Gelre Hospital, Postbus 9014, 7300DS, Apeldoorn, The Netherlands., Troost MM; Department of Medical Oncology, Bravis Hospital Bergen op Zoom, Postbus 999, 4700AZ, Roosendaal, The Netherlands., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Postbus 1926, 5900BX, Venlo, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Heerlen, Postbus 5500, 6130MB, Sittard-Geleen, The Netherlands., van der Pas AJM; Department of Medical Oncology, LangeLand Hospital, Postbus 3015, 2700KJ, Zoetermeer, The Netherlands., van der Velden AMT; Department of Medical Oncology, Tergooi, Van Riebeeckweg 212, 1213XZ, Hilversum, The Netherlands., van Dijk MA; Department of Medical Oncology, ZorgSaam Hospital, Wielingenlaan 2, 4535PA, Terneuzen, The Netherlands., van Dodewaard-de Jong JM; Department of Medical Oncology, Meander Medical Center, Postbus 1502, 3800BM, Amersfoort, The Netherlands., van Druten EB; Department of Medical Oncology, Reinier de Graaf Gasthuis, Postbus 5011, 2600GA, Delft, The Netherlands., van Voorthuizen T; Department of Medical Oncology, Hospital Rijnstate, Wagnerlaan 55, 6815AD, Arnhem, The Netherlands., Jan Veldhuis G; Department of Medical Oncology, Antonius Hospital Sneek, Postbus 20000, 8600BA, Sneek, The Netherlands., Verheul HMW; Department of Medical Oncology, Amsterdam University Medical Center, VU Medical Center, P.O. Box 7057, 1007MB, Amsterdam, The Netherlands., Vestjens HJHMJ; Department of Medical Oncology, VieCuri Medical Center, Postbus 1926, 5900BX, Venlo, The Netherlands., Vincent J; Department of Medical Oncology, Elkerliek Hospital, Postbus 98, 5700AB, Helmond, The Netherlands., Kranenburg OW; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Postbus 98, 5700AB, Utrecht, The Netherlands.; Utrecht Platform for Organoid Technology, University Medical Center Utrecht, Utrecht University, Postbus 98, 5700AB, Utrecht, The Netherlands., Punt CJA; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Postbus 22660, Amsterdam, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands. M.Koopman-6@umcutrecht.nl.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Jan; Vol. 124 (2), pp. 399-406. Date of Electronic Publication: 2020 Oct 13.

Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer.

Autor: Keikes L; Department of Medical Oncology, Amsterdam University Medical Centers, Location AMC, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: l.keikes@amc.uva.nl., de Vos-Geelen J; Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands. Electronic address: judith.de.vos@mumc.nl., de Groot JWB; Department of Medical Oncology, Isala, Zwolle, the Netherlands. Electronic address: j.w.b.de.groot@isala.nl., Punt CJA; Department of Medical Oncology, Amsterdam University Medical Centers, Location AMC, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: c.punt@amc.uva.nl., Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Veldhoven, the Netherlands. Electronic address: Lieke.Simkens@mmc.nl., Trajkovic-Vidakovic M; Department of Medical Oncology, Albert Schweitzer Hospital, Dordrecht, the Netherlands. Electronic address: m.vidakovic@asz.nl., Portielje JEA; Department of Medical Oncology, Haga Hospital, The Hague, the Netherlands. Electronic address: J.Portielje@hagaziekenhuis.nl., Vos AH; Department of Medical Oncology, Hospital Bernhoven, Uden, the Netherlands. Electronic address: a.vos@bernhoven.nl., Beerepoot LV; Department of Medical Oncology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands. Electronic address: l.beerepoot@etz.nl., Hunting CB; Department of Medical Oncology, Antonius Hospital, Nieuwegein, the Netherlands. Electronic address: j.hunting@antoniusziekenhuis.nl., Koopman M; Department of Medical Oncology, University Medical Center, Utrecht, the Netherlands. Electronic address: M.Koopman-6@umcutrecht.nl., van Oijen MGH; Department of Medical Oncology, Amsterdam University Medical Centers, Location AMC, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: m.g.vanoijen@amc.uva.nl.

Publikováno v: Patient education and counseling [Patient Educ Couns] 2019 Jul; Vol. 102 (7), pp. 1331-1335. Date of Electronic Publication: 2019 Feb 22.

Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group.

Autor: Kwakman JJM; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam., Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Eindhoven., van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Venlo., Ten Tije AJ; Department of Medical Oncology, Amphia Hospital, Breda., Creemers GJM; Department of Medical Oncology, Catharina Hospital, Eindhoven., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar., Los M; Department of Medical Oncology, Sint Antonius Hospital, Nieuwegein., van Alphen RJ; Department of Medical Oncology, TweeSteden Hospital, Tilburg., Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden., Muller EW; Department of Medical Oncology, Slingeland Hospital, Doetinchem., van der Velden AMT; Department of Medical Oncology, Tergooi Hospital, Hilversum., van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Arnhem., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht., Mol L; Clinical Trial Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Jun 01; Vol. 28 (6), pp. 1288-1293.